home / stock / avcnf / avcnf news

AVCNF News and Press, Avicanna Inc From 04/18/24

Stock Information
Company Name: Avicanna Inc
Stock Symbol: AVCNF
Market: OTC
Website: avicanna.com
Menu
AVCNF AVCNF Quote AVCNF Short AVCNF News AVCNF Articles AVCNF Message Board
Get AVCNF Alerts

News, Short Squeeze, Breakout and More Instantly...
AVCNF - Avicanna Announces Closing of Non-brokered Private Placement

TORONTO, April 18, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based pro...
AVCNF - Avicanna Announces Completion of Topical Gel Observational Real-World Evidence Study

TORONTO, April 10, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based pro...

AVCNF - Avicanna reports FY results

2024-04-02 10:09:43 ET More on Avicanna Avicanna Inc. (AVCNF) Q4 2023 Earnings Call Transcript Avicanna signs supply and licensing agreement with pharmaceutical company Read the full article on Seeking Alpha For further details see: Avicanna reports FY re...

AVCNF - Avicanna Inc. (AVCNF) Q4 2023 Earnings Call Transcript

2024-04-02 09:54:02 ET Avicanna Inc. (AVCNF) Q4 2023 Earnings Call Transcript April 02, 2024 08:30 AM ET Company Participants Aras Azadian - Chief Executive Officer Phillip Cardella - Chief Financial Officer Conference Call Participants Presentation ...
AVCNF - Avicanna Reports Full Year 2023 Audited Financial Results 

$16.8M in Revenue, representing an increase of 314% from 2022 $6.7M Consolidated gross Profit, representing an increase of 500% from 2022 TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ) (TSX: AVCN) (OTCQX: AVCNF) ...

AVCNF - Avicanna Announces the Canadian Launch of 10% CBD (THC Free) Proprietary Formulation

The 10% CBD (THC free) proprietary oral formulation branded as RHO Phyto Micro Drop 100 in Canada RHO Phyto Micro Drop 100 is available exclusively at MyMedi.ca. TORONTO, March 27, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company )...

AVCNF - Avicanna To Hold Full Year 2023 Earnings Conference Call

TORONTO, March 26, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or “ Company ”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based produc...
AVCNF - Avicanna Hosts Symposium on Cannabinoid-based Medicine  

TORONTO, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is ...

AVCNF - Avicanna Announces New Research Collaboration with a Multi-national European-based Pharmaceutical Company

TORONTO, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is ...

AVCNF - Avicanna Obtains Its First Indication-Specific Drug Registration with Trunerox(TM)

TORONTO, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is ...
Previous 10 Next 10